Salivary mucins MG1 and MG2 have been found in the oral cavity where they perform several functions such as the formation of the mucous layer covering the oral mucosa and teeth. Recent studies have demonstrated their presence in other organs and tissues. The aim of this study was to determine their expression in human bulbourethral (Cowper's) glands. Normal bulbourethral glands were obtained at surgery and fixed in a mixture of 1% paraformaldehyde-1.25% glutaraldehyde in 0.1 M cacodylate buffer and embedded in Epon resin. Thin sections were labeled with rabbit antibodies to MG1 or to an N-terminal synthetic peptide of MG2, followed by gold-labeled goat anti-rabbit IgG. The granules of all mucous cells were intensely reactive with anti-MG1, whereas no labeling was detected for MG2. These results indicate that MG1 is not exclusively a salivary component and furthermore show that bulbourethral glands represent a significant source of the MG1 detected in human seminal plasma.
Introduction
Mucins represent a first line of defence for mucosal surfaces against bacterial, fungal and viral attacks. Their glycosidic groups bind to specific components of microbial walls, thus mediating the entrapment and clearance of bacteria from the body tracts. Human mucosal linings produce chemically different mucins depending on the functional necessities in terms of lubrication and hydration maintenance, and even probably on the microorganisms that may come into contact with them. For example, saccharide chains of salivary mucins recognize Candida albicans , Streptococcus mutans , and Helicobacter pylori (May et al. 1989; Namavar et al. 1998; Ligtenberg et al. 2000) , thus constituting a first barrier to their entry into the digestive tract. Recently, a strong inhibitory action of salivary mucins has been demonstrated towards HIV infection (Habte et al. 2006) . Several studies also documented the expression of a variety of mucins in the human genital tracts, especially of the female, and some relations with reproductive physiology were assessed (Lagow et al. 1999) .
Previously distinguished and classified on the basis of their molecular weight and amounts of saccharide groups, mucins are now more precisely identified by the sequence of their apomucin. The first recognized were MG1 and MG2 mucins, and their encoding genes MUC5B and MUC7 were also defined (Bobek et al. 1993; Thornton et al. 1999 ). MG1 and MG2 are generally mentioned as typical salivary mucins, as they were first identified in human saliva, and are also known as high and low molecular weight salivary mucins, respectively. Antibodies directed to both mucins have been obtained and utilized to better analyze their presence in saliva and salivary glands (Troxler et al. 1997; Liu et al. 1999) , and their secretion by salivary glands has been confirmed by immunohistochemical findings (Piludu et al. 2003) .
The MG1 core protein possesses many cysteine residues that form disulfide-bonded complexes. This feature allows MG1 to form a gelatinous covering that efficaciously protects the inner surfaces of the mouth. In contrast, MG2 is believed to act in a soluble form as it is produced as a monomer.
Although defined as salivary mucins, MG1 and MG2 also are expressed in other organs (e.g. Sharma et al. 1998; Lagow et al. 1999) . In this study, we have tested the possibility that MG1 and MG2 are expressed in human bulbourethral (Cowper's) glands, which release their mucinous secretions into the male urethra.
Materials and methods
The human samples used in this study were chosen from the wide collection of embedded tissues stored over the course of many years and kindly placed at our disposal by Professor A. Riva, University of Cagliari. Human bulbourethral glands had been dissected from four consenting patients aged 52-74 years during radical cystectomies at the urologic clinic of the University of Cagliari. All procedures had been approved by the Human Experimentation Committee, University of Cagliari. The samples had been immediately cut into small fragments and fixed in a mixture of 1% paraformaldehyde and 1.25% glutaraldehyde in 0.1 M cacodylate buffer for 2 h, then rinsed in the same buffer, dehydrated in ethanol, and embedded in Epon resin (Glycide Ether 100, Merck, Darmstadt, Germany). Although post fixation with osmium tetroxide is usually omitted in immunohistochemical experiments, some osmicated pieces were also included in this experiment to better discern the two secretory components, granules and filamentous bodies, that characterize these glands.
Ultrathin sections were collected on nickel grids and treated with 1% bovine serum albumin (BSA)-1% instant milk in PBS to block nonspecific binding. Some sections were incubated with rabbit polyclonal antibodies to MG1 (Troxler et al. 1995) diluted 1:100 in 1% BSA-5% normal goat serum (NGS) in PBS for 60 min at room temperature. Other sections were incubated with a rabbit polyclonal antibody to an N-terminal synthetic peptide of MG2 (Liu et al. 1999 ) diluted 1:50 in fish gelatin, ovalbumin, and Tween-20 in PBS overnight at 4 ºC. Previous studies with the anti-MG2 antibody showed that this blocking solution was more effective than one containing BSA and normal goat serum (Piludu et al. 2003) . Control sections were incubated with a medium devoid of the primary antiserum or with nonimmune rabbit serum. All the grids were rinsed with PBS and then incubated with goat anti-rabbit IgG labeled with 15-nm gold particles (Amersham, Arlington Heights, IL, USA) diluted 1:50 in 1% BSA-PBS for 60 min at room temperature. After rinsing in PBS and distilled water, the grids were stained with uranyl acetate and bismuth subnitrate, and observed and photographed in a JEOL 100S electron microscope.
Results
MG1 immunolabeling was revealed in the secretory endpieces of all glands examined in this study (Figs 1 and 2) , whereas MG2 did not react at all. As expected, staining was much more intense in non-osmicated samples ( Figs 1A  and 2) .
In bulbourethral glands, secreting cells appeared filled with typical pale and often confluent mucous granules, which were specifically stained for MG1. Filamentous bodies, which represent the other secretory material in bulbourethral glands, were discernible for their peculiar texture only in osmicated samples, even after they fused with granules (Testa-Riva et al. 1994) . In non-osmicated samples, they appeared as rather dense masses, a few showing a scanty labeling (Fig. 2) . Most likely, these labeled masses correspond to filamentous bodies already fused with mucous granules, where only the mucous component reacted.
All other organelles, nuclei and membranes were unlabeled.
Control sections were always negative.
Discussion
The present results show that human bulbourethral glands secrete MG1, adding evidence that MG1 is not exclusively a salivary component, so that its definition as salivary mucin now appears obsolete. Previous studies by Russo et al. (2006) demonstrated the presence of MG1 (MUC5B) in human seminal plasma, but did not identify its source. The present study indicates that the bulbourethral glands represent a source of the MG1 in semen. Although the functional importance of seminal MG1 in reproductive physiology is completely unknown, it could be hypothesized that, like other mucins (Lagow et al. 1999) , it influences the sperm transport in the male and female genital tracts. The secretions of bulbourethral glands, although never analysed separately, are believed to consist of a mixture of acidic mucins, as deduced by studies with conventional histochemistry (Riva et al. 1981; Sirigu et al. 1991) . Previous immunohistochemical studies (Cossu et al. 1994 ) demonstrated the blood group reactive substances ABH, Le-a, and Le-b in the mucous granules of both urethral and bulbourethral glands in conformity with the blood group type and secretor status, and hypothesized that such saccharide groups were associated with mucins. The present findings suggest that in the bulbourethral glands, blood group antigens are present only on MG1. Data obtained with human saliva support this hypothesis, in that Le-a, Le-b, and ABH antigen saccharides were shown to be preferentially carried by MG1 (Prakobphol et al. 1993) . As blood group antigens represent receptor sites that mediate specific interactions with many microorganisms, the functional importance of MG1 is probably to supply the urethral canal with receptors that can entrap microorganisms and prevent infections. As MG1 belongs to the gel-forming type of mucins, it is expected that this mucin covers the inner urethral surface with a dense protective film firmly adherent to the epithelium. Most likely, other mucins also are secreted by bulbourethral glands, which are segregated in the filamentous bodies as in mucous cells of human salivary glands (Harrison et al. 1987 ) and mix with the mucous granules in the late phases of secretion (Testa Riva et al. 1994) . The filamentous bodies also may contain other substances. We previously showed that cyclic AMP receptor proteins (the type II regulatory subunit of protein kinase A) are associated with the filamentous component of these structures in mucous cells of human salivary glands (Piludu et al. 2002) .
The absence of MG2 labeling suggests that bulbourethral glands do not produce this mucin, similarly to the human cervix, which expresses MG1 but not MG2 (Gipson, 2001) . However, we cannot rule out the possibility that MG2 is present at concentrations below the detection limit of our immunogold labeling procedures, or that differences in its molecular conformation in the these glands reduce its reactivity with the antibody. At variance with MG1, this low molecular weight mucin does not have gel-forming properties, but it enters the secreted fluids as a dissolved monomer (Bobek et al. 1993; Sharma et al. 1998) . In human saliva, it is thought to take part in the continuous clearance of the oral cavity, due particularly to its antimicrobial and antifungal activities (Bobek & Situ, 2003) . These activities meet specific requirements of the mouth, which is the most accessible cavity in the human body to infectious agents, especially during food ingestion. The male urethra, although also in close vicinity to the external environment, is less exposed to extraneous materials than the mouth, so its clearance is achieved in a less complex way. For this reason, the real absence of MG2 in the secretion of bulbourethral glands appears conceivable. Although they did not examine the bulbourethral glands, Russo et al. (2006) found no evidence for synthesis of MG2 (MUC7) in the male reproductive tract, including the urethra. Habte et al. (2006) recently demonstrated that both salivary MG1 and MG2 mucins inhibit HIV-1 activity, and suggested that this property should prevent oral transmission of HIV. The present results apparently contrast with this hypothesis, in that the same inhibitory effects should be exerted by urethral MG1 towards the viruses that gain access to the urethra during sexual intercourse. It is likely that the inhibitory effects of MG1 in urethral mucus are not sufficient to prevent HIV transmission because the virus concentration in sexual fluids generally is significantly higher than in saliva (Cohen et al. 2000) . Moreover, the lack of the clearance and protective actions of MG2, as well as other salivary components that exhibit anti-HIV activity (Moutsopoulous et al. 2006) , in the male genital tract might represent one of the factors that determine the higher abundance of HIV in semen compared with saliva.
